BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16956659)

  • 1. Chronic myelomonocytic leukemia with overlap dysplastic/proliferative presentation.
    Gologan R; Stoia R; Radulescu I; Georgescu D; Ostroveanu D
    Leuk Res; 2007 Jun; 31(6):878-9. PubMed ID: 16956659
    [No Abstract]   [Full Text] [Related]  

  • 2. Topoisomerase I inhibitors in the treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M
    Leuk Res; 2004 May; 28(5):443-6. PubMed ID: 15068895
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical CML with massive splenic infarct: an extremely rare presentation.
    Bandyopadhyay D; Manna S; Hajra A; Bhattacharya TD
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26564117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea induced leg ulcers.
    Abhyankar D; Shende C; Saikia T; Advani SH
    J Assoc Physicians India; 2000 Sep; 48(9):926-7. PubMed ID: 11198798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [beta-thalassemia minor diagnosed in a patient with chronic myelogenous leukemia during hydroxyurea therapy].
    Chiba K; Kurosawa M; Kondo T; Suzuki S; Musashi M; Asaka M; Imamura M; Hattori Y; Oba Y
    Rinsho Ketsueki; 2000 Jan; 41(1):61-4. PubMed ID: 10695401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priapism as a presentation of hematological malignancy.
    Singh BP; Gupta NP; Choudhry VP
    J Assoc Physicians India; 1995 Apr; 43(4):297. PubMed ID: 8713276
    [No Abstract]   [Full Text] [Related]  

  • 7. Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia.
    Campiotti L; Grandi AM; Biotti MG; Ultori C; Solbiati F; Codari R; Venco A
    Am J Hematol; 2007 Mar; 82(3):231-3. PubMed ID: 17022045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Symmetrical foot ulcer in chronic myeloid leukemia treated with hydroxyurea (Litalir)].
    Reichenberger F
    Praxis (Bern 1994); 1998 Oct; 87(41):1370-2. PubMed ID: 9828669
    [No Abstract]   [Full Text] [Related]  

  • 9. Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome.
    Isoda A; Nakahashi H; Hoshino T; Mitsui T; Yoshida Y
    Am J Hematol; 2007 Jun; 82(6):501-2. PubMed ID: 17301971
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic myelomonocytic leukemia: myelodysplastic or myeloproliferative?
    Itzykson R; Fenaux P; Solary E
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):387-400. PubMed ID: 24507815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent Sweet's syndrome and leukemia cutis in patients with myeloid disorders.
    del Pozo J; Martínez W; Pazos JM; Yebra-Pimentel MT; García Silva J; Fonseca E
    Int J Dermatol; 2005 Aug; 44(8):677-80. PubMed ID: 16101872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of drug-induced colitis complicating the administration of hydroxycarbamide.
    Sadamoto Y; Ueda T; Matsumoto M; Kubokawa M; Ito K; Kubo H; Tanaka M; Harada N; Muta K; Nawata H; Takata M; Yao T
    Endoscopy; 2002 Jun; 34(6):511. PubMed ID: 12048644
    [No Abstract]   [Full Text] [Related]  

  • 13. Azacitidine-eligibility in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukaemia: a registry-based study.
    Durairaj S; Keenan N; Hyslop A; Groves MJ; Bowen DT; Tauro S
    Br J Haematol; 2013 Apr; 161(2):280-2. PubMed ID: 23294041
    [No Abstract]   [Full Text] [Related]  

  • 14. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.
    Navarro JT; Feliu E; Grau J; Espinet B; Colomer D; Ribera JM; Oriol A; Granada I; Juncà J; Millá F
    Am J Hematol; 2007 Sep; 82(9):849-51. PubMed ID: 17563075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR-ABL positive chronic myeloid leukemia with concurrent JAK2(V617F) positive myelodysplastic syndrome/myeloproliferative neoplasm (RARS-T).
    Gattenlohner S; Völker HU; Etschmann B; Einsele H; Müller-Hermelink HK
    Am J Hematol; 2009 May; 84(5):306-7. PubMed ID: 18951468
    [No Abstract]   [Full Text] [Related]  

  • 16. Uncommon of the uncommon: low-grade myelodysplastic syndrome evolving into chronic myelogenous leukemia.
    Zhang L; Bennett JM; Zhang X; Moscinski L; Ibarz-Pinilla J; List AF; Komrokji R
    J Clin Oncol; 2011 May; 29(15):e434-6. PubMed ID: 21149648
    [No Abstract]   [Full Text] [Related]  

  • 17. Images in clinical medicine. Roth's spots.
    Varga Z; Pavlu J
    N Engl J Med; 2005 Sep; 353(10):1041. PubMed ID: 16148289
    [No Abstract]   [Full Text] [Related]  

  • 18. [Leg ulcer due to hydroxyurea. A case report].
    Gning SB; Debonne JM; Diagne-Guèye NM; Ndiaye B; Fall F; Mbaye PS
    Dakar Med; 2006; 51(2):89-91. PubMed ID: 17632983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib.
    Woo SM; Huh CH; Park KC; Youn SW
    J Dermatol; 2007 Oct; 34(10):724-6. PubMed ID: 17908148
    [No Abstract]   [Full Text] [Related]  

  • 20. [MRI of splenomegaly].
    Kurihara M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):577-83. PubMed ID: 2235308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.